NEWS
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements
Quantum BioPharma (NASDAQ:QNTM) has regained compliance with Nasdaq's minimum bid price requirement, ensuring continued listing on the exchange.
Quantum BioPharma (NASDAQ:QNTM) has regained compliance with Nasdaq's minimum bid price requirement, ensuring continued listing on the exchange.
The company has also completed debt settlements of $450,000 each with three executives through the issuance of 248,160 Class B Shares at $5.44 per share. Additionally, Quantum BioPharma announced a non-brokered private placement of up to 6 Class A Shares at $6.00 per share, expected to be subscribed by entities controlled by Zeeshan Saeed and Anthony Durkacz. This offering aims to increase Class A Share voting rights to 64.13%. The company also granted 12,500 stock options and 7,500 RSUs to a director and consultants, and cancelled 7,692 warrants previously granted to a board member.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2329Followers
106Following
24KVisitors
Follow